About: Prevention of experimental coronavirus colds with intranasal alpha-2b interferon

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevention of experimental coronavirus colds with intranasal alpha-2b interferon Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1986

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1986 (uk) article scientifique publié en 1986 (fr) im September 1986 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1986 (ast) scientific article published on 01 September 1986 (en) գիտական հոդված հրատարակված 1986 թվականի սեպտեմբերի 1-ին (hy)
publication date	wds:Q70144481-43C3E733-722E-4F10-9459-4F9251EE179F
publication date	1986-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70144481-1B542F9C-D79D-40F9-8416-04C647140D18
language of work or name	English
author name string	wds:Q70144481-94633245-EB52-41B8-8A8F-5F183DA8CC1D wds:Q70144481-A3A3AB9E-CFFC-47EC-BAB9-10783373B1DF wds:Q70144481-B55F08B9-4EED-40FC-A06B-044F3B03053E wds:Q70144481-E9661673-F349-411E-8575-A8D78ECBC00A wds:Q70144481-F76D59E1-B13B-4A31-A03C-EC7501E4573D
author name string	D K Kelsey R B Turner C K Meschievitz A Felton K Kosak
rdfs:label	Prevention of experimental coronavirus colds with intranasal alpha-2b interferon (en) Prevention of experimental coronavirus colds with intranasal alpha-2b interferon (nl)
skos:prefLabel	Prevention of experimental coronavirus colds with intranasal alpha-2b interferon (en) Prevention of experimental coronavirus colds with intranasal alpha-2b interferon (nl)
name	Prevention of experimental coronavirus colds with intranasal alpha-2b interferon (en) Prevention of experimental coronavirus colds with intranasal alpha-2b interferon (nl)
title	wds:Q70144481-2F7AAD52-D5A7-4B17-937C-097AECC873F1
title	Prevention of experimental coronavirus colds with intranasal alpha-2b interferon (en)
page(s)	wds:Q70144481-1E14861C-3D38-4A48-B0DA-EBDC9D8DEFCD
page(s)	443-447
instance of	wds:Q70144481-E9B82F9E-7BF3-457B-B6FE-89063E266B9F
instance of	scholarly article
main subject	wds:Q70144481-346F4121-F039-4585-8CEE-414EABCBE22C wds:Q70144481-CE792370-1D41-4141-A2BE-196ED40DED6A
main subject	Coronaviridae Immunology and allergy
PubMed ID	wds:Q70144481-D6955575-0E0E-498C-B555-3A5D76ACFAF7
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3016111
PubMed ID	3016111
published in	wds:Q70144481-748595E8-83F3-48FC-B579-A878D3A85F92
published in	Journal of Infectious Diseases
issue	wds:Q70144481-8E57E79C-1B94-45CF-8728-1A0A7351ABCF
volume	wds:Q70144481-A80DCDB7-8317-410C-8215-7D266F158F20
issue	3
volume	154
DOI	wds:Q70144481-30ABB969-FF32-4851-A376-50C367842091
DOI	http://dx.doi.org/10.1093/INFDIS/154.3.443
DOI	10.1093/INFDIS/154.3.443
PMCID	wds:Q70144481-A257C852-9527-4356-95E9-79AE002BF251
PMCID	7110151
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70144481
is cites work of	Structural requirements for O-glycosylation of the mouse hepatitis virus membrane protein Role of interferons in the treatment of severe acute respiratory syndrome Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Coronaviruses and their therapy Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease The management of coronavirus infections with particular reference to SARS. Viral-bacterial synergistic interaction in respiratory disease. Interferons as therapeutic agents for infectious diseases. Pneumonia in pediatric outpatients: cause and clinical manifestations Intranasally administered alpha/beta interferon prevents extension of mouse hepatitis virus, strain JHM, into the brains of BALB/cByJ mice Antiviral therapy for respiratory tract infections Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro Oral application of cytokines Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer Antiviral agents WITHDRAWN: Antivirals for the common cold Potential interventions for novel coronavirus in China: A systematic review Use of Hydroxychloroquine and Interferon alpha-2b for the Prophylaxis of COVID-19 The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event COVID-19: Transmission, Prevention, and Potential Therapeutic Opportunities Combined antiviral-antimediator treatment for the common cold Development of antiviral therapy for severe acute respiratory syndrome. Antiviral chemotherapy and prophylaxis of viral respiratory disease A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon Safety and tolerance of ocular administration of recombinant alpha interferon New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention Ahead of a vaccine: A safe method of protection against COVID-19 exists Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis The future of antiviral chemotherapy
is cites work of	wds:Q37298680-6B8E1853-B5DC-4609-A122-B4D721C501FF wds:Q41115941-FD1C82BB-75A2-4751-BA7A-21D871CBA1B4 wds:Q74619199-B469B518-19FF-4A11-ABC3-99F15D6F6A86 wds:Q95632491-CCC8D1CF-DBF5-43D9-8EFA-9601CF00E0F4 wds:Q34012358-6D38ED3A-9987-4D8E-B486-1EC105901D80 wds:Q33291075-50D053DB-0684-4BDC-BF39-D169F7B65A0D wds:Q39817471-742D65D8-DAC0-4D03-A1B4-CB7D41798158 wds:Q40557821-01787F23-C899-48BE-A0D7-0F3AC7B27184 wds:Q35880180-D34C4A4A-50BE-422A-8BDC-3F9D70FB4044 wds:Q30457345-996C8617-8C86-41BE-B4E4-87C35C3BA1F4 wds:Q30309659-7821A6F4-5D8A-4A0F-BDDA-38BAC822003E wds:Q44446032-C32F4FC5-BE46-4F1D-A332-9992A77037A9 wds:Q92117598-A6F9918D-CCE0-4D27-AF81-E6852F6FE8C2

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 182 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software